BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30108319)

  • 1. Familial total anomalous pulmonary venous return with 15q11.2 (BP1-BP2) microdeletion.
    Kuroda Y; Ohashi I; Naruto T; Ida K; Enomoto Y; Saito T; Nagai JI; Yanagi S; Ueda H; Kurosawa K
    J Hum Genet; 2018 Nov; 63(11):1185-1188. PubMed ID: 30108319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15q11.2 microdeletion (BP1-BP2) and developmental delay, behaviour issues, epilepsy and congenital heart disease: a series of 52 patients.
    Vanlerberghe C; Petit F; Malan V; Vincent-Delorme C; Bouquillon S; Boute O; Holder-Espinasse M; Delobel B; Duban B; Vallee L; Cuisset JM; Lemaitre MP; Vantyghem MC; Pigeyre M; Lanco-Dosen S; Plessis G; Gerard M; Decamp M; Mathieu M; Morin G; Jedraszak G; Bilan F; Gilbert-Dussardier B; Fauvert D; Roume J; Cormier-Daire V; Caumes R; Puechberty J; Genevieve D; Sarda P; Pinson L; Blanchet P; Lemeur N; Sheth F; Manouvrier-Hanu S; Andrieux J
    Eur J Med Genet; 2015 Mar; 58(3):140-7. PubMed ID: 25596525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal diagnosis of a familial 15q11.2 (BP1-BP2) microdeletion encompassing TUBGCP5, CYFIP1, NIPA2 and NIPA1 in a fetus with ventriculomegaly, microcephaly and intrauterine growth restriction on prenatal ultrasound.
    Chen CP; Chang SY; Wang LK; Chang TY; Chern SR; Wu PS; Chen SW; Lai ST; Chuang TY; Yang CW; Town DD; Chen LF; Wang W
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):730-733. PubMed ID: 30342661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic, Clinical, and Behavioral Characterization of 15q11.2 BP1-BP2 Deletion (Burnside-Butler) Syndrome in Five Families.
    Baldwin I; Shafer RL; Hossain WA; Gunewardena S; Veatch OJ; Mosconi MW; Butler MG
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial transmission of recurrent 15q11.2 (BP1-BP2) microdeletion encompassing NIPA1, NIPA2, CYFIP1, and TUBGCP5 associated with phenotypic variability in developmental, speech, and motor delay.
    Chen CP; Lin SP; Lee CL; Chern SR; Wu PS; Chen YN; Chen SW; Wang W
    Taiwan J Obstet Gynecol; 2017 Feb; 56(1):93-97. PubMed ID: 28254235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay.
    Burnside RD; Pasion R; Mikhail FM; Carroll AJ; Robin NH; Youngs EL; Gadi IK; Keitges E; Jaswaney VL; Papenhausen PR; Potluri VR; Risheg H; Rush B; Smith JL; Schwartz S; Tepperberg JH; Butler MG
    Hum Genet; 2011 Oct; 130(4):517-28. PubMed ID: 21359847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15q11.2 proximal imbalances associated with a diverse array of neuropsychiatric disorders and mild dysmorphic features.
    Abdelmoity AT; LePichon JB; Nyp SS; Soden SE; Daniel CA; Yu S
    J Dev Behav Pediatr; 2012 Sep; 33(7):570-6. PubMed ID: 22922608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic aspects of the 15q11.2 BP1-BP2 microdeletion disorder.
    Butler MG
    J Intellect Disabil Res; 2017 Jun; 61(6):568-579. PubMed ID: 28387067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parent-of-Origin Effects in 15q11.2 BP1-BP2 Microdeletion (Burnside-Butler) Syndrome.
    Davis KW; Serrano M; Loddo S; Robinson C; Alesi V; Dallapiccola B; Novelli A; Butler MG
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of 15q11.2(BP1-BP2) region: further evidence for lack of phenotypic specificity in a pediatric population.
    Hashemi B; Bassett A; Chitayat D; Chong K; Feldman M; Flanagan J; Goobie S; Kawamura A; Lowther C; Prasad C; Siu V; So J; Tung S; Speevak M; Stavropoulos DJ; Carter MT
    Am J Med Genet A; 2015 Sep; 167A(9):2098-102. PubMed ID: 25946043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine ultrasound phenotyping, molecular characteristics, and postnatal follow-up of fetuses with the 15q11.2 BP1-BP2 microdeletion syndrome: a single-center, retrospective clinical study.
    Cai M; Lv A; Zhao W; Xu L; Lin N; Huang H
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):23. PubMed ID: 38172840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modest impact on risk for autism spectrum disorder of rare copy number variants at 15q11.2, specifically breakpoints 1 to 2.
    Chaste P; Sanders SJ; Mohan KN; Klei L; Song Y; Murtha MT; Hus V; Lowe JK; Willsey AJ; Moreno-De-Luca D; Yu TW; Fombonne E; Geschwind D; Grice DE; Ledbetter DH; Lord C; Mane SM; Martin DM; Morrow EM; Walsh CA; Sutcliffe JS; State MW; Martin CL; Devlin B; Beaudet AL; Cook EH; Kim SJ
    Autism Res; 2014 Jun; 7(3):355-62. PubMed ID: 24821083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and magnesium levels: Novel insights in 15q11.2 BP1-BP2 copy number variants.
    Meossi C; Carrer A; Ciaccio C; Estienne M; Silipigni R; Sciacca FL; Pantaleoni C; D'Arrigo S; Milani D
    J Intellect Disabil Res; 2023 Jul; 67(7):679-689. PubMed ID: 37129092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic Diversity of 15q11.2 BP1-BP2 Deletion in Three Korean Families with Development Delay and/or Intellectual Disability: A Case Series and Literature Review.
    Han JY; Park J
    Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33921555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15q11.2 microdeletion and FMR1 premutation in a family with intellectual disabilities and autism.
    Madrigal I; Rodríguez-Revenga L; Xunclà M; Milà M
    Gene; 2012 Oct; 508(1):92-5. PubMed ID: 22842191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic features in patients with 15q11.2(BP1-BP2) deletion: further delineation of an emerging syndrome.
    Cafferkey M; Ahn JW; Flinter F; Ogilvie C
    Am J Med Genet A; 2014 Aug; 164A(8):1916-22. PubMed ID: 24715682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment.
    Murthy SK; Nygren AO; El Shakankiry HM; Schouten JP; Al Khayat AI; Ridha A; Al Ali MT
    Cytogenet Genome Res; 2007; 116(1-2):135-40. PubMed ID: 17268193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium Supplement and the 15q11.2 BP1-BP2 Microdeletion (Burnside-Butler) Syndrome: A Potential Treatment?
    Butler MG
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31207912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No signs of neurodegenerative effects in 15q11.2 BP1-BP2 copy number variant carriers in the UK Biobank.
    Boen R; Kaufmann T; Frei O; van der Meer D; Djurovic S; Andreassen OA; Selmer KK; Alnæs D; Sønderby IE
    Transl Psychiatry; 2023 Feb; 13(1):61. PubMed ID: 36807331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances.
    Doornbos M; Sikkema-Raddatz B; Ruijvenkamp CA; Dijkhuizen T; Bijlsma EK; Gijsbers AC; Hilhorst-Hofstee Y; Hordijk R; Verbruggen KT; Kerstjens-Frederikse WS; van Essen T; Kok K; van Silfhout AT; Breuning M; van Ravenswaaij-Arts CM
    Eur J Med Genet; 2009; 52(2-3):108-15. PubMed ID: 19328872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.